Trial intelligence / Profile preview

GDPT vs CHOP in Peripheral T-cell Lymphoma

NCT01664975Phase 4Completed

Start
Aug 2011
Primary completion
Apr 2016
Modality
Nanoparticles, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of gemcitabine, Cisplatin micelle injection (HA132), prednisone, thalidomide in peripheral T-cell lymphoma (PTCL). Started Aug 2011; status: completed.

02

Drugs

gemcitabineCisplatin micelle injection (HA132)prednisonethalidomide
03

Conditions

peripheral T-cell lymphoma (PTCL)

Beyond the preview

Go deeper on NCT01664975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01664975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call